Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
CONCORDBIO Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Weak price momentum
Analysts have been downgrading forward EPS estimates
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High ROE but declining trend
High operating margin but declining trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
CONCORDBIO Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
CONCORDBIO Bulk, Block & Insider Trades
CONCORDBIO Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Concord Biotech Limited is an India-based research and development-driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. Its business verticals include active pharmaceutical ingredients (API), finished form... Read More
Key personnel
Mr. Sudhir Kumar VaidD
Executive Chairman of the Board, Managing Director
Mr. Ankur VaidD
Chief Executive Officer, Joint Managing Director, Executive Director
Mr. Raviraj Karia
Chief Financial Officer
Ms. Hina Patel
Company Secretary and Compliance Officer
Mr. Devang Bhatt
Vice President - Sales and Marketing, Head - Limbasi Plant - 3
Dr. Manoj Kumar
Vice-President - Formulation Division and Head - Valthera Unit - 2
Mr. Sundeep Bengani
General Manager - International Business Development, Formulation Division
Mr. Rajiv Ambrish AgarwalD
Non-Executive Nominee Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Concord Biotech Ltd.?
The current share price of Concord Biotech Ltd. is ₹ 1,320.50 as of 09 Jan 2026.
What is the PE ratio of Concord Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Concord Biotech Ltd. is 42.71 as of the latest financial data.
What is the ROE and ROCE of Concord Biotech Ltd.?
Concord Biotech Ltd. has a Return on Equity (ROE) of 18.93% and a Return on Capital Employed (ROCE) of 21.87% as per the latest financial reports.
What is the market cap of Concord Biotech Ltd.?
The market capitalization of Concord Biotech Ltd. stands at ₹ 13,814.50 Cr.
What is the dividend yield of Concord Biotech Ltd.?
The dividend yield of Concord Biotech Ltd. is 0.81% based on the current market price.
What is the RSI of Concord Biotech Ltd.?
The Relative Strength Index (RSI) of Concord Biotech Ltd. is 39.96.
What is the FII and DII holding in Concord Biotech Ltd.?
Foreign Institutional Investors (FII) hold 8.03% and Domestic Institutional Investors (DII) hold 8.43% of Concord Biotech Ltd. shares.
What sector does Concord Biotech Ltd. belong to?
Concord Biotech Ltd. operates in the Healthcare sector.
What is the beta of Concord Biotech Ltd. stock?
The beta of Concord Biotech Ltd. stock is 0.71, indicating its volatility relative to the broader market.
